- NHS & GPhC approved UK pharmacy
- Rated Excellent on Trustpilot (8,100+ reviews)
- Tracked, discreet Royal Mail delivery
- Every order pharmacist-checked
Royal Mail tracked 24 or 48 hour delivery in plain, unmarked packaging.
Pharmacy, clinic and prescribers based in Greater Manchester.
Where a prescription is needed, the price you see includes your consultation and prescription.
Royal Mail tracked 24 or 48 hour delivery in plain, unmarked packaging.
Pharmacy, clinic and prescribers based in Greater Manchester.
Where a prescription is needed, the price you see includes your consultation and prescription.
Fill in a quick online consultation for our licensed pharmacists to review.
Our pharmacists will review your treatment to ensure it’s suitable.
Your treatment will be delivered to your door quickly & discreetly.
| Medication Name | Migraleve Pink Tablets |
|---|---|
| Medication Form | Tablets |
| Used for | Migraine pain and associated nausea and vomiting |
| Active Ingredients | Paracetamol, codeine phosphate, buclizine hydrochloride |
| Strength | Paracetamol 500 mg, codeine phosphate 8 mg, buclizine hydrochloride 6.25 mg |
| Patient Information Leaflet | Migraleve Pink Patient Information Leaflet |
Migraleve Pink tablets are a short-term treatment for moderate pain that hasn’t been relieved by paracetamol, ibuprofen or aspirin alone, such as migraine attacks. They treat the pain of a migraine headache as well as the nausea and vomiting that often come with it.
You should take them at the first sign of a migraine. Taken at this point, they can stop the attack from developing.
If your migraine carries on, you can follow them with Migraleve Yellow tablets, which contain the same pain relief ingredients without the anti-sickness medicine.
If Migraleve doesn’t help your migraines, there are other treatments available, including triptans such as almotriptan.
Migraleve Pink tablets contain three active ingredients that treat different migraine symptoms:
Migraleve Pink tablets can be used by adults and children aged 12 and over who have been diagnosed with migraines by a doctor. However, at Click2Pharmacy, we can only sell this medicine for use by adults over 18.
Do not use:
You can only take one dose of Migraleve Pink tablets (2 tablets) in any 24-hour period.
If the migraine continues, take 2 Migraleve Yellow tablets, 4 hours after the pink dose and then every 4 hours as needed. Do not take more than 8 tablets (2 pink and 6 yellow) in a 24-hour period.
Do not take for more than 3 days in a row. If your symptoms persist, speak to your doctor or pharmacist.
Like all medications, Migraleve Pink tablets may cause side effects. These may not affect everybody, and most side effects are usually mild.
These may affect more than 1 in 10 people:
These may affect up to 1 in 10 people:
These may affect up to 1 in 100 people:
The frequency of these side effects isn’t known:
Stop taking Migraleve Pink tablets and tell your doctor straight away if you get:
For a full list of side effects, read the patient information leaflet provided.
If you notice any side effects, tell your doctor or pharmacist, even if they are not listed here. You can also report side effects through the Yellow Card Scheme. This helps improve the safety of this medicine.
It’s best to avoid alcohol while taking Migraleve Pink tablets. Alcohol can make you more drowsy and adds to the sedating effects of the codeine and buclizine they contain.
Don’t take Migraleve Pink tablets if you’re breastfeeding, as codeine and morphine can pass into breast milk. If you’re pregnant, speak to your doctor or pharmacist before using them.
Migraleve Pink tablets are a pharmacy medicine, so you don’t need a prescription. You can order them through our online migraine clinic after a quick consultation. We’ll ask for photo ID to confirm you’re over 18 before we supply them.
Always take Migraleve Pink tablets first, at the first sign of a migraine. If the pain continues, you can take Migraleve Yellow tablets 4 hours later and then every 4 hours as needed. Don’t take more than one Pink dose in 24 hours.
Migraleve Pink tablets contain paracetamol and codeine for pain, plus buclizine to help relieve nausea and vomiting. Migraleve Yellow tablets contain paracetamol and codeine but no buclizine. They’re used to treat continuing migraine symptoms and should always be taken after a first dose of Migraleve Pink.
Adults can take one dose of 2 Migraleve Pink tablets in 24 hours. If you need more pain relief, you can follow this with Migraleve Yellow tablets. Don’t take more than 8 tablets in total (2 pink and 6 yellow) in 24 hours.
Don’t take Migraleve Pink tablets for more than 3 days in a row. The codeine they contain can cause addiction if taken continuously for longer than this, and using painkillers for headaches too often can make them worse. Speak to your doctor if your migraines keep coming back.
Don’t take any other medicine that contains paracetamol while you’re taking Migraleve Pink tablets, as this could lead to an overdose. Many cold and flu remedies contain paracetamol, so check the label. Don’t take Migraleve Pink tablets within 4 hours of taking any other painkillers, and speak to a pharmacist before taking other medicines containing codeine or similar opioids.
Sleepiness is a very common side effect of Migraleve Pink tablets, although it can also be a symptom of migraine itself. Don’t drive until you know how the tablets affect you.
Migraleve should only be taken when you need it. If you forget a dose, take the next one when needed as long as your last dose was at least 4 hours ago. Don’t take a double dose, and remember you can only take one Pink dose in 24 hours.
Talk to a doctor straight away if you take too much Migraleve Pink, even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage.
“Migraleve Pink tablets combine pain relief with an anti-sickness medicine, so they’re an option to consider if nausea is part of your migraines. Take them as soon as you notice the first signs of an attack and don’t use them for more than 3 days in a row.”
Dr Hussain Ahmad
Page content authored by Amjad Khan, last reviewed by Dr Hussain Ahmad on 5th November 2026.
